Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | UDP N acetylglucosamine dolichyl phosphate | 0.0033 | 0.0267 | 0.4754 |
Plasmodium falciparum | UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase, putative | 0.0033 | 0.0267 | 0.5 |
Mycobacterium ulcerans | lipase LipD | 0.0043 | 0.0408 | 0.0145 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.0408 | 0.7267 |
Mycobacterium ulcerans | phospho-N-acetylmuramoyl-pentapeptide-transferase | 0.0778 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | phospho-N-acetylmuramoyl-pentapeptide-transferase | 0.0778 | 1 | 0.5 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0043 | 0.0408 | 0.7267 |
Onchocerca volvulus | 0.0033 | 0.0267 | 0.6542 | |
Onchocerca volvulus | 0.0043 | 0.0408 | 1 | |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0.0408 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0408 | 0.7267 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0043 | 0.0408 | 1 |
Brugia malayi | beta-lactamase | 0.0043 | 0.0408 | 0.7267 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0408 | 0.7267 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.0408 | 1 |
Chlamydia trachomatis | phospho-N-acetylmuramoyl-pentapeptide-transferase | 0.0296 | 0.3702 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0043 | 0.0408 | 1 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0043 | 0.0408 | 0.7267 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0043 | 0.0408 | 0.7267 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0043 | 0.0408 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0562 | 1 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0043 | 0.0408 | 0.7267 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0408 | 0.7267 |
Toxoplasma gondii | ABC1 family protein | 0.0043 | 0.0408 | 1 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0.0408 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0562 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0562 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0562 | 1 |
Schistosoma mansoni | UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase | 0.0033 | 0.0267 | 0.4754 |
Loa Loa (eye worm) | beta-lactamase | 0.0043 | 0.0408 | 0.7267 |
Entamoeba histolytica | UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase, putative | 0.0033 | 0.0267 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.0408 | 1 |
Mycobacterium ulcerans | beta-lactamase | 0.0043 | 0.0408 | 0.0145 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0562 | 1 |
Giardia lamblia | UDP-N-acetylglucosamine-dolichyl-phosphateN-acetylglucosaminephosphotransferase | 0.0033 | 0.0267 | 0.5 |
Mycobacterium tuberculosis | Probable phospho-N-acetylmuramoyl-pentappeptidetransferase MurX | 0.0778 | 1 | 1 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0278 | 0.3468 | 0.319 |
Treponema pallidum | phospho-N-acetylmuramoyl-pentapeptide-transferase (mraY) | 0.0296 | 0.3702 | 0.5 |
Onchocerca volvulus | 0.0043 | 0.0408 | 1 | |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0562 | 1 |
Echinococcus multilocularis | UDP N acetylglucosamine dolichyl phosphate | 0.0033 | 0.0267 | 0.4754 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0043 | 0.0408 | 0.7267 |
Schistosoma mansoni | UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase | 0.0033 | 0.0267 | 0.4754 |
Trichomonas vaginalis | esterase, putative | 0.0043 | 0.0408 | 1 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0043 | 0.0408 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0408 | 0.7267 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0043 | 0.0408 | 0.0145 |
Onchocerca volvulus | 0.0043 | 0.0408 | 1 | |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0562 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0562 | 1 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0043 | 0.0408 | 0.7267 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0267 | 0.4754 |
Mycobacterium ulcerans | hypothetical protein | 0.0043 | 0.0408 | 0.0145 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0562 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0043 | 0.0408 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0408 | 0.7267 |
Brugia malayi | UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase | 0.0033 | 0.0267 | 0.4754 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0408 | 0.7267 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.0408 | 0.7267 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0043 | 0.0408 | 0.0145 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0.0408 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1.9953 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 2.8184 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 8.9125 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 14.7157 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.